The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
NCT03073902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2018-12-28
Summary
The detection of tissue PD-L1 immunohistochemistry in Non-small cell lung cancer (NSCLC) has an important role in guiding for the treatment of immune detection point. At the same time,tissue detection is time-consuming and laborious, liquid biopsy can reflect the information of tumor tissue,PD-L1 expression in serum and peripheral blood T cell are expected to be simple, rapid, non-invasive means of detection. The project is planned to explore the correlation of PD-L1 expression in non-small lung cancer tissue and peripheral blood T cell and serum..The investigators have designed to detected the expression levels of PD-L1 protein in cancer tissue and detected the expression levels of PD-L1 in peripheral blood T cell and serum.By using variance analysis of repeated measures design information. Thus exploring the correlation of PD-L1 expression in non-small lung cancer tissue and peripheral blood T cell and serum,guiding clinical practice of immunotherapy.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Liquid biopsy
Liquid biopsy
Sponsors & Collaborators
-
Xinqiao Hospital of Chongqing
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-25
- Primary Completion
- 2018-03-31
- Completion
- 2018-12-10
Countries
- China
Study Locations
More Related Trials
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer
NCT05928299 ·Status: COMPLETED
-
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance
NCT05933863 ·Status: COMPLETED
-
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes
NCT05792995 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Value of PD-L1 in NSCLC
NCT03078959 ·Status: UNKNOWN
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
NCT07119190 ·Status: NOT_YET_RECRUITING
-
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients
NCT05129462 ·Status: COMPLETED
-
Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients
NCT04203095 ·Status: UNKNOWN
-
PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer
NCT05533086 ·Status: UNKNOWN
-
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer
NCT03258788 ·Status: COMPLETED
-
PD-L1 Expression in Lung Cancer
NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2
-
The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
NCT06287320 ·Status: RECRUITING
-
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
NCT06849518 ·Status: RECRUITING ·Phase: NA
-
Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study
NCT07331701 ·Status: NOT_YET_RECRUITING
-
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 ·Status: COMPLETED
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
irAE Prediction of Anti-PD-1/L1 in Lung Cancer
NCT05288569 ·Status: UNKNOWN
-
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
NCT02855281 ·Status: COMPLETED
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
NCT06768853 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512 ·Status: RECRUITING
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING